Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-1/A IPO registration
- 1.1 EX-1.1
- 3.1 EX-3.1
- 3.3 EX-3.3
- 3.4 EX-3.4
- 4.1 EX-4.1
- 4.2 EX-4.2
- 5.1 EX-5.1
- 10.1 EX-10.1
- 10.2 EX-10.2
- 10.3 EX-10.3
- 10.4 EX-10.4
- 10.5 EX-10.5
- 10.6 EX-10.6
- 10.8 EX-10.8
- 10.9 EX-10.9
- 10.10 EX-10.10
- 10.11 EX-10.11
- 10.12 EX-10.12
- 10.13 EX-10.13
- 10.14 EX-10.14
- 10.15 EX-10.15
- 10.16 EX-10.16
- 10.17 EX-10.17
- 23.1 EX-23.1
EVLO similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated March 5, 2018, except for Note 15a, as to which the date is April 13, 2018 and Note 15b, as to which the date is April 30, 2018, in Amendment No. 1 to the Registration Statement (FormS-1No. 333-224278) and related Prospectus of Evelo Biosciences, Inc. for the registration of 6,109,375 shares of its common stock.
/s/ Ernst & Young LLP
Boston, MA
April 30, 2018